Ademi LLP announces that a class action lawsuit has been filed on September 9, 2024 in the United States District Court for the Southern District of New York on behalf of a class of individuals and entities (the “Class”) that held common stock of Taro Pharmaceutical Industries Ltd. (NYSE: TARO), asserting claims under Sections 14(a) and 20(a) of the Securities Exchange Act of 1934 in connection with the sale of Taro to Sun Pharmaceutical Industries Ltd.
